Luke Seikkula
Geschäftsführer bei LA JOLLA PHARMACEUTICAL COMPANY
Aktive Positionen von Luke Seikkula
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Geschäftsführer | 01.01.2019 | - |
Karriereverlauf von Luke Seikkula
Ehemalige bekannte Positionen von Luke Seikkula
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2012 | 01.01.2015 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Corporate Officer/Principal | 01.01.2009 | 01.01.2012 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.01.1991 | 01.01.2001 |
| LA JOLLA PHARMACEUTICAL COMPANY | Corporate Officer/Principal | 01.01.2001 | - |
Ausbildung von Luke Seikkula
| Winona State University | Undergraduate Degree |
| San Diego State University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
Operativ
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
- Börse
- Insiders
- Luke Seikkula
- Erfahrung
